Journal News

Mapping out the protein path to hearing

Briana James
By Briana James
Aug. 6, 2024

When sound-induced vibrations are translated into electrochemical signals, humans and other animals can hear those sounds. Within the cochlea of the inner ear, inner hair cells, or IHCs, release neurotransmitter-filled vesicles at their synapse with afferent neurons, sending auditory information to the brain. Some researchers suspect a unique network of trafficking proteins and organelles is involved in this neurotransmission. However, scientists do not know the identities for most of these molecular players.

Previous studies reported a general protein profile of IHCs by analyzing whole cochleas. However, these studies did not identify the proteins found specifically in the IHC’s presynaptic regions, where vesicles are released.

Apical turn of an organ of Corti of an adult mouse, showing VGluT3 expression, magenta, in inner hair cells.
Apical turn of an organ of Corti of an adult mouse, showing VGluT3 expression, magenta, in inner hair cells.

Andreia Cepeda, who studied deafness during her Ph.D. at the University Medical Center Goettingen, wanted to uncover these details.  

“One of the challenges has been the scarcity of material needed for these kinds of studies which require large amounts of purified sample,” Cepeda said. “Obtaining enough starting material from these IHCs is an extremely difficult and time-consuming task.”

To tackle this challenge, Cepeda teamed up with Momchil Ninov, who specializes in isolating synaptic vesicles, and others from the Max Planck Institute. The group developed a protocol that led to the first complete map of the IHC proteome, which they published in their recent article in Molecular & Cellular Proteomics.

Before identifying IHC proteins, the team had to isolate enough samples from mice for proteomic analysis, Cepeda’s most challenging task.

“I was the only one dissecting the cochleas,” she said, “and I had entire weeks where I was dissecting every day, all day simply to collect enough material.”

Cepeda and Ninov said they isolated roughly 150 organs of Corti per run, the receptor organs where the IHCs are located, from these cochleas — which further reduced the amount of sample they had to work with.

“Imagine how many cochleas (and how many mice) we need to obtain enough material to be used for further purification,” Ninov said. “To give you an idea, one starts with the cochlea of a mouse, which is about the size of a grain of rice, and under the microscope, we need to dissect (the organ of Corti), which is the size of a needle’s head.”

Though tedious, this step notably improved their sample purity for downstream analysis.

Following dissection and homogenization, the group separated the samples into subcellular fractions by differential centrifugation. Then they immunoisolated IHC-specific vesicles and organelles using an antibody against VGluT3, a glutamate transporter expressed exclusively in IHCs. This resulted in an enriched, albeit limited amount of material ready to be characterized by mass spectrometry. The group had access to a sophisticated mass spectrometer allowing them to identify proteins in very small amounts.

Using this workflow, the team introduced the first exhaustive list of proteins involved in vesicle trafficking at the IHC presynapse. They also noted significant developmental changes in this molecular profile by measuring proteins before and after the onset of hearing. The group further validated the proteins by confocal microscopy but they say that more needs to be done. Knocking down these proteins in animal models along with recent advances in the study of membrane trafficking could reveal key synaptic physiology contributing to deafness.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Briana James
Briana James

Briana James is a postdoctoral fellow at the National Institutes of Health with an interest in science policy and communication. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.